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Background: Cholera is an acute diarrheal disease caused by Vibrio cholerae. Outbreaks are caused by a genetically
homogenous group of strains from serogroup O1 or O139 that are able to produce the cholera toxin. Rapid
detection and identification of these epidemic strains is essential for an effective response to cholera outbreaks.
Results: The use of ferulic acid as a matrix in a new MALDI-TOF MS assay increased the measurable mass range of
existing MALDI-TOF MS protocols for bacterial identification. The assay enabled rapid discrimination between epidemic
V. cholerae O1/O139 strains and other less pathogenic V. cholerae strains. OmpU, an outer membrane protein whose
amino acid sequence is highly conserved among epidemic strains of V. cholerae, appeared as a discriminatory marker in
the novel MALDI-TOF MS assay.
Conclusions: The extended mass range of MALDI-TOF MS measurements obtained by using ferulic acid improved the
screening for biomarkers in complex protein mixtures. Differences in the mass of abundant homologous proteins due
to variation in amino acid sequences can rapidly be examined in multiple samples. Here, a rapid MALDI-TOF MS assay
was developed that could discriminate between epidemic O1/O139 strains and other less pathogenic V. cholerae strains
based on differences in mass of the OmpU protein. It appeared that the amino acid sequence of OmpU from epidemic
V. cholerae O1/O139 strains is unique and highly conserved.Background
Cholera is an acute diarrheal disease caused by Vibrio
cholerae that can be lethal within hours if left untreated.
In 2011, a total of 589,854 cases were registered from 58
countries, including 7,816 deaths [1]. The severity, dur-
ation, and frequency of cholera epidemics appear to be
increasing [2], indicating that cholera is a severe public
health problem. In addition, V. cholerae is considered a
category B bioterrorism agent by the CDC [3]. Infection
usually occurs by consumption of contaminated water,
the natural habitat of V. cholerae, or contaminated food.
Within the V. cholerae species, over 200 serogroups have
been identified but only serogroup O1 and O139 strains* Correspondence: armand.paauw@TNO.nl
1Department of CBRN Protection, TNO, P.O. Box 45, Rijswijk 2280 AA, The
Netherlands
Full list of author information is available at the end of the article
© 2014 Paauw et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.that are able to produce cholera enterotoxin (CT) and
toxin-coregulated pilus (TCP) can cause epidemics. The
toxigenicity of a V. cholerae strain depends on its ability
to produce the CT, encoded by the ctxAB genes, and
TCP, encoded by the Vibrio pathogenicity island (VPI)
[4]. However, these virulence factors are also described
in non-O1/O139 V. cholerae isolates without causing an
epidemic threat [5]. Next, occasionally, other strains of
V. cholerae may cause diarrhea, but they do not have
epidemic potential [6]. Rapid detection and identification
of threatening microorganisms is essential for an effect-
ive response to an infectious disease outbreak. There-
fore, rapid discrimination between epidemic V. cholerae
O1/O139 strains and other V. cholerae strains is crucial.
Matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS) is increasingly used
for quick identification of bacteria and possesses advantagesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cheap and suitable for high-throughput identification
[7-10]. The discriminatory power of MALDI-TOF MS in
analysis of whole bacterial cell lysates overlaid with α-
cyano-4-hydroxycinnamic acid as a matrix is usually suffi-
cient to identify bacteria to the species level but may also
be used to differentiate between strains belonging to one
species if adequate protein extraction procedures are per-
formed [11-15]. The aim of this study was to develop a
MALDI-TOF MS assay able to discriminate between toxi-
genic and epidemic V. cholerae O1/O139 strains and other
mostly non-O1/O139 isolates. To extend the measurable
range of the MALDI-TOF MS and thereby increase the
discriminatory power of the MS spectra, ferulic acid was
used as a matrix [16,17]. The outer membrane protein
OmpU was identified as a suitable biomarker for discrim-




In total, 48 clinical and environmental isolates of V.
cholerae and Vibrio mimicus (Table 1) were obtained
from Instituto Tecnológico La Marañosa, Spanish Minis-
try of Defence, San Martín de la Vega, Madrid, Spain,
Norwegian Defence Research Establishment, Kjeller,
Norway, and Military Institute of Hygiene and Epidemi-
ology, Pulawy, Poland (Table 1) [18-20]. The human iso-
lates were all collected as part of standard patient care. The
isolates were collected from different areas of the world.
Thirty-three, three, and twelve isolates were serotyped as
O1, O139, and non-O1/O139 serogroups, respectively.
From the 33 serogroup O1 isolates, 18 were clinical iso-
lates, 10 were environmental isolates, and five isolates were
from an unknown source. Two serogroup O139 isolates
were clinical isolates and one was of unknown origin. From
the isolates not belonging to serogroup O1 or O139, two
isolates were of clinical origin and the 10 remaining isolates
were of environmental origin.
Confirmation of strain identification
Identification of the isolates at species level was confirmed
by MALDI-TOF MS using Biotyper 2.0 (Bruker Daltonics
GmbH, Bremen, Germany) [11]. Serogroup and serotype
were confirmed using the Vibrio cholerae E Agglutinating
Sera kit containing specific antisera O1 polyvalent agglutin-
ation serum, Inaba agglutination serum, and Ogawa agglu-
tination serum (Remel Europe Ltd. Darford, Kent, United
Kingdom) according to the manufacturer’s guidelines.
Genotyping of isolates with multilocus sequence typing
(MLST) analysis
MLST analysis was performed according to Teh et al. [21].
Internal gene fragments of dnaE, lap, recA, gyrB, and catwere PCR amplified and sequenced. The gmd gene was
not included in the analysis due to low discriminatory
power [21]. Each sequence variant of a locus was assigned
a distinct allele number. In the case that no PCR product
could be obtained for a specific allele, the number zero was
assigned. The allele profiles were entered into BioNumerics
version 6.6 software (Applied-Maths, Belgium) as character
values, and the genetic relationship between isolates was
constructed using the categorical coefficient and the Mini-
mum Spanning Tree algorithm. Isolates that differed at
two or fewer loci were considered genetically closely re-
lated, while single locus variants (SLV) were defined as
having at least three alleles that were different from all
other tested isolates.
Isolates were screened for the presence of the viru-
lence genes ctxAB and tcpA by PCR [21]. Template
DNA was obtained from supernatants of cell suspen-
sions lysed by heating for 10 min at 95°C. Amplification
of DNA fragments from dnaE, lap, recA, gyrB, cat,
ompU, ctxAB, and tcpA was performed with a HotStar
Taq MasterMix kit (Qiagen, Westburg b.v., Leusden,
The Netherlands). The primers used were previously de-
scribed by Teh et al. [21]. The ompU genes from 9 iso-
lates (including three epidemic strains (080025/EZ [O1
Ogawa], FFIVC130 [O139], and FFIVC129 [O1 Hikojima]),
six environmental isolates (FFIVC114, 080025/FE, 080025/
FI, 080025/FL, 17/110/2006, and 2/110/2006) were ampli-
fied using the primers ompU-fw (5′-ACCTATTTCGATT
GACGTGGC-3′) and ompU-rv (5′-ACATCCACCAAG
AAACGTTGC-3′), which anneal approximately 80 bp up-
and downstream of the ompU open reading frames. The
PCR products were bidirectionally sequenced. DNA se-
quencing was performed by BaseClear B.V. (Leiden, The
Netherlands).
Sample preparation for MALDI-TOF MS analysis
V. cholerae isolates were grown for 16 h at 35°C on
blood agar plates. Sample preparation for MALDI-TOF
MS analysis of whole cell lysates was performed as pre-
viously described [11]. Each isolate sample was spotted
eight times on the MALDI target. Four spots were over-
laid with 0.5 μl of 10 mg/ml α-cyano-4-hydroxycinnamic
acid (HCCA, Bruker Daltonics) in an acetonitrile/
water solution (1:1) with 2.5% trifluoroacetic acid (Fluka/
Aldrich, Stenheim, Germany). Four spots were overlaid
with 0.5 μl of a matrix solution containing 12.5 mg/ml
ferulic acid (Sigma-Aldrich), 17% formic acid and 33%
acetonitrile (LC-MS grade, Fluka/Aldrich, Stenheim,
Germany), hereafter referred to as FA+ [16,17]. Spots
were dried at room temperature.
Mass spectra acquisition
The mass spectra were acquired automatically on a Bruker
Autoflex III smartbeam instrument (Bruker Daltonics) in
Table 1 V. cholerae isolates analyzed in this study
Presence (1) or absence (0)
of virulence genes
Allelic variants of targeted
genes in MLSTa




cat dnaE gyrB lap recA MSP
valueb
Referencec
080025/EY Vib12, F 751 O1 Ogawa 1 1 0 1990 Human Spain 1 1 1 1 1 1 2.48 [18,19]
080025/EZ Vib13, F 752 O1 Ogawa 1 1 0 1990 Human Spain 1 1 1 1 1 1 2.17 [18,19]
080025/FA Vib14, F 753 O1 Ogawa 1 1 0 1990 Human Spain 1 1 1 1 1 1 2.46 [18,19]
080025/FB Vib15, F 754 O1 Ogawa 1 1 0 1990 Human Spain 1 1 1 1 1 1 2.30 [18,19]
080025/FC Vib16, F 755 O1 Ogawa 1 1 0 1990 Human Spain 1 1 1 1 1 1 2.36 [18,19]
080025/FD Vib17, F 756 O1 Ogawa 1 1 0 1990 Water Spain 1 1 1 1 1 1 2.19 [18,19]
080025/FE Vib18, F 758 O1 Inaba 0 0 0 1991 Water Spain 2 13 0 5 8 12 2.38 [18,19]
080025/FF Vib19, F 759 O1 Inaba 0 0 0 1991 Water Spain 2 12 0 5 8 12 2.22 [18,19]
080025/FG Vib20, F 760 O1 Inaba 0 0 0 1991 Water Spain 2 12 0 5 8 12 2.22 [18,19]
080025/FH Vib21, F 761 O1 Inaba 0 0 0 1991 Prawn Ecuador 2 12 0 3 9 12 2.21 [18,19]
080025/FI Vib22, F 763 O1 Inaba 0 0 0 1991 Prawn Ecuador 2 13 0 3 9 13 2.19 [18,19]
080025/FJ Vib23, F 762 O1 Inaba 0 0 0 1991 Prawn Ecuador 2 12 0 3 9 12 2.32 [18,19]
080025/FK Vib24, F 764 O1 Inaba 0 0 0 1991 Prawn Ecuador 2 12 0 3 9 12 2.30 [18,19]
080025/FL Vib25, F 766 O1 Ogawa 0 0 0 1992 Water Spain 3 9 8 11 7 8 2.37 [18,19]
080025/FM Vib26, F 768 O1 Ogawa 1 1 0 1992 Human Spain 1 1 1 1 1 1 2.15 [18,19]
080025/FN Vib27, F 767 O1 Ogawa 1 1 0 1992 Human Spain 1 1 1 1 1 1 2.47 [18,19]
080025/FO Vib28, F 765 O1 Inaba 0 0 0 1991 Prawn Ecuador 2 13 0 3 9 12 2.25 [18,19]
080025/FP Vib29 O1 Ogawa 1 1 0 1993 Human Spain 1 1 1 1 1 1 2.18 [18]
080025/FQ Vib30 O1 Ogawa 1 1 0 1993 Human Spain 1 1 1 1 1 1 2.40 [18]
080025/FS Vib32 O1 Ogawa 0 0 0 1994 Human Spain 3 9 0 11 7 8 2.17 [18]
080025/FT Vib33 O1 Ogawa 1 1 0 1994 Human Spain 1 1 1 1 1 1 2.22 [18]
080025/FU Vib34 O1 Ogawa 1 1 0 1994 Human Spain 1 1 1 1 1 1 2.37 [18]
080025/FV Vib35 O1 Ogawa 1 1 0 1994 Human Spain 1 1 1 1 1 1 2.50 [18]
080025/FW Vib36 O1 Ogawa 1 1 0 1995 Human Spain 1 1 1 1 1 1 2.37 [18]
080025/FX Vib37 O1 Ogawa 1 1 0 1995 Human Spain 1 1 1 1 1 1 2.48 [18]
080025/GD Vib43 O1 Ogawa 1 1 0 unknown unknown 1 2 1 1 1 2 2.37 [18]
080025/GE Vib44 O1 Inaba 0 0 1 unknown unknown 3 9 0 11 7 0 2.45 [18]
FFIVC057 2/23 O1 Ogawa 1 1 0 1994 Epidemic Italy 1 1 1 1 1 1 2.50 [20]
FFIVC058 2/26 O1 Ogawa 1 1 0 1994 Epidemic Italy 1 1 1 1 1 1 2.46 [20]


















Table 1 V. cholerae isolates analyzed in this study (Continued)
FFIVC129 ATCC 33655 O1 Hikojima 1 0 1 1979 unknown unknown 1 2 1 1 1 2 1.99 [20]
FFIVC016 O1 Ogawa 1 0 1 unknown unknown 1 2 1 1 1 2 2.39 [20]
14/2002/S O1 Unknown 1 1 0 unknown unknown 1 1 1 1 0 1 2.42 [20]
FFIVC130 ATCC51394 O139 1 1 0 1995 Human India 1 1 1 1 1 1 2.37 [20]
FFIVC131 CDC2412-93 O139 1 1 0 1995 Human USA 1 1 1 1 1 1 2.43 [20]
FFIVC133 O139 1 1 0 2003 unknown unknown 1 1 1 1 1 1 2.49 [20]
080025/FR Vib31 O141 1 1 1 1993 Human Spain singleton 8 7 3 2 9 2.24 [18]
FFIVC050 non O1/O139 0 0 0 Mussels Norway singleton 8 9 9 11 5 2.28 [20]
FFIVC084 non O1/O139 0 0 0 2003 Mussels Norway singleton 4 2 4 3 3 2.45 [20]
FFIVC114 non O1/O139 0 0 0 2004 Water Norway 4 6 1 6 6 6 2.29 [20]
FFIVC115 non O1/O139 0 0 0 2004 Water Norway 4 6 1 6 6 6 2.39 [20]
FFIVC137 non O1/O139 0 0 0 Human Norway singleton 7 5 8 10 4 2.41 [20]
2/110/2006 non O1/O139 0 0 0 1998 Water Poland 5 10 4 2 12 4 2.25 [18]
3/110/2006 non O1/O139 0 0 0 1998 Water Poland 5 10 4 2 12 4 2.42 [18]
4/110/2006 non O1/O139 0 0 0 2004 Water Poland singleton 11 0 13 0 11 2.38 [18]
14/110/2006 non O1/O139 0 0 0 1998 Water Poland singleton 5 3 10 4 7 2.37 [18]
17/110/2006 non O1/O139 0 0 0 1998 Water Poland 6 3 6 7 5 10 2.47 [18]
22/110/2006 non O1/O139 0 0 0 2004 Water Poland 6 3 6 7 5 10 2.26 [18]
070256/J V. mimicus
ATCC 33655
- 1 0 0 10 14 10 12 1 14 1.71 [18]
a“0” means no PCR product was obtained.
bMSP value: highest logarithmic value of the four generated MS-spectra score value compared to Biotyper reference library.


















Paauw et al. BMC Microbiology 2014, 14:158 Page 5 of 14
http://www.biomedcentral.com/1471-2180/14/158linear mode. Spots overlaid with HCCA matrix were ana-
lyzed using the following parameters: 50% laser intensity,
positive polarity, 350 ns PIE delay, acceleration voltage of
20 kV (source 1) and 18.7 kV (source 2), lens voltage of
8 kV, linear detector voltage of 1.522 kV, and 500 Da de-
tector gating. Composite mass spectra were generated
from 10 different positions per spot using, in total, 2,000
laser shots at each spot generated by a 200-Hz smartbeam
laser (355 nm). The mass spectra were recorded in a mass/
charge (m/z) range of 2,000 – 20,000. The parameters used
for analysis of the spots overlaid with the FA+matrix were:
80% laser intensity, positive polarity, 350 ns PIE delay,
acceleration voltage of 20 kV (source 1) and 18.7 kV
(source 2), lens voltage of 2.8 kV, linear detector voltage
of 1.522 kV, and 4000 Da detector gating. Composite
mass spectra were generated from 10 different positions
per spot using, in total, 2,000 laser shots at each spot
generated by a 200-Hz smartbeam laser (355 nm). The
mass spectra were recorded in a m/z range of 4,000 –
80,000. The instrument was externally calibrated with a
bacterial test standard (BTS, Bruker Daltonics) when
analyzing HCCA-overlaid spots or peptide calibration
standard II (Bruker Daltonics) when analyzing spots
overlaid with FA+. To evaluate the reproducibility of the
newly developed method, the entire test was repeated on
a separate day.
Data analysis MS spectra
The MS spectra obtained from the spots overlaid with
the HCCA matrix were analyzed using MALDI Biotyper
2.0 software and Bruker’s security relevant library (Bruker
Daltonics). These libraries together contain 83 reference
spectra (MSPs) from various Vibrio species, including
three V. cholerae strains and one V. mimicus strain. For
each measurement, a logarithmic score value was deter-
mined by calculating the proportion of matching peaks
and peak intensities between the test spectrum and the
reference spectra of the database [11,13]. Identification at
species level was based on the highest of the four loga-
rithmic values [11]. All MS spectra obtained from spots
overlaid with the FA+ matrix were analyzed using Matlab
software (version R2011b). The spectra were first con-
verted into the MZXML format using the Bruker Daltonics
supplied software (CompassXport) and subsequently
converted to the Matlab binary format using mzxml read
procedure. Further processing was performed using the
Matlab Bioinformatics toolbox (Version 4.0) routines
such as resampling (msresample - mass range 10,000 to
50,000 Da and resampling to 5,000 data points), baseline
subtraction (msbackadj), alignment on a peak mass of
11974 (msalign), which was present in the MS spectra
of all V. cholerae isolates, normalization (msnorm) and
visualization of spectra in a heat map. Peaks were auto-
matically selected using standard peak selection algorithm(mspeaks - HeightFilter = 2). The highest peak in the
region of 32.5 – 37.5 kDa per isolate was automatically
identified.
Protein identification by SDS-PAGE coupled to LC-MS/MS
Viable cells of the V. cholerae isolates FFIVC129,
FFIVC130, 080025/EZ, 080025/FC, 080025/FE, 080025/FI,
FFIVC137 and 17/110/2006 were resuspended in 50 μl
phosphate-buffered saline and mixed with 50 μl Laemmli
2x sample buffer (Bio-Rad). Samples were incubated at
100°C for 10 minutes and analyzed by standard SDS-
PAGE using a 12% polyacrylamide gel and Coomassie
Brilliant Blue staining [22]. The most prominent protein
bands in the mass range of 34 to 38 kDa were excised
from the gel and subjected to in-gel trypsin digestion.
Gel pieces were washed with pure water, destained with
three rounds of washing in a mixture of 70% 25 mM
NH4HCO3/30% acetonitrile (ACN) and dehydrated by
10 minutes of incubation in 100% ACN. After removal of
ACN, gel pieces were incubated in 100 mM NH4HCO3/
10 mM dithiothreitol for 30 min at 56°C followed by
addition of iodoacetamide to a final concentration of
55 mM and 30 min of incubation at room temperature.
Gel pieces were washed in 25 mM NH4HCO3, dehy-
drated by incubation in 100% ACN, placed in 50 μl
100 mM NH4HCO3 containing 10 ng/ml trypsin (from
bovine pancreas, Sigma-Aldrich) and incubated overnight
at 37°C. The remaining liquid was transferred to a clean
tube, and peptides were extracted from the gel pieces by
two rounds of 5 minute incubation in 50 μl 60% ACN,
1% trifluoroacetic acid in an ultrasonic bath (37 kHz).
The combined fractions were dried in a SpeedVac, and
the pellets were resuspended in 30 μl H2O. The sam-
ples were analyzed by liquid chromatography-tandem
mass spectrometry using an Ultimate 3000 RSLnano
LC system (Thermo Scientific, Sunnyvale, CA) coupled
to an HCTultra ion trap mass spectrometer (Bruker
Daltonics). Samples were injected onto an Acclaim C18
PepMap100 trapping column (Thermo Scientific) and
washed with 100% buffer A (3% ACN in 0.1% formic
acid) at 5 μl /min for 6 min. Peptides were separated on
an Acclaim C18 PepMap RSLC column at a constant flow
rate of 300 nl/min. An elution gradient of 3 to 40% buffer
B (95% ACN in 0.1% formic acid) was applied over
48 min followed by an increase to 65% B in 10 min. The
nanoflow LC was coupled to the mass spectrometer using
a nano-electrospray ionization source. Eluting peptides
were analyzed using the data-dependent MS/MS mode
over a 300–1500m/z range. The five most abundant ions
in an MS spectrum were selected for MS/MS analysis by
collision-induced dissociation using helium as collision
gas. Peak lists were generated using DataAnalysis 4.0 soft-
ware (Bruker Daltonics) and exported as Mascot Generic
files. These files were searched against the NCBI database
Figure 1 Minimal Spanning Tree (MST) of V. cholerae isolates
based on MLST data. Each circle corresponds to a sequence
type. The number of partitions in each circle corresponds to the
number of isolates. Single locus variants are connected with a solid
line; two single variants are connected with a dotted line. Red,
serogroup O1 serotype Ogawa strains (GT1); purple, serogroup O139
(GT1); dark blue, serogroup O1 serotype Hikojima (GT1); yellow,
serogroup O1 serotype Inaba (GT2); pink, serogroup O1 serotype
Ogawa (2x) and Inaba (1x) (GT3). Green, brown and light blue,
non-O1 or O139 serogroup strains (GT4, GT5, GT6). Gray, V. mimicus.
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2.2.1) search algorithm (Matrix Science, London, UK).
Trypsin was selected as the enzyme for digestion and up
to one missed cleavage site was allowed. Carbamidomethyl
cysteine was selected as a fixed modification, and oxida-
tion of methionine was selected as a variable modification.
Results
Strain identification
Forty-eight isolates acquired from different strain collec-
tions (Table 1) and previously identified as V. cholerae
were analyzed using MALDI-TOF MS and Biotyper 2.0
software (Bruker Daltonics). All strains were identified
as V. cholerae with matching scores of 1.99 to 2.51 fol-
lowing the highest matching score rule [11]. As a con-
trol, one V. mimicus isolate was analyzed, which resulted
in a matching score value of 1.71, indicating a ‘probable
genus identification’. In addition, serogroup and serotype
designations were confirmed using specific antisera.
MLST analysis
To determine the genetic relationship among the 48
V. cholerae isolates, a MLST analysis was performed.
Accession numbers: cat KF421252 - KF421300, dnaE
KF421301 - KF421338, gyrB KF421339 - KF421387, lap
KF421388 - KF421434, and recA KF421435 - KF421482.
The isolates were differentiated into six different ge-
notypes (GT1-6) and six single locus variants (SLVs)
(Table 1). The presence of the virulence genes ctxAB
and tcpA was determined by PCR. All isolates of ser-
ogroups O1 or O139 that contained the ctxAB and tcpA
were highly related (Figure 1). Within this group, all O1
isolates contained the type-specific antigen of the sero-
type Ogawa with the exception of one isolate that
belonged to serotype Hikojima and one isolate of un-
known serotype. V. cholerae O1 strains of serotype
Hikojima are considered to be rare [23]. Isolates outside
the GT1 group were determined to be negative for ctxAB
with the exception of one SLV, an isolate of serogroup
O141 that contained ctxAB and tcpA. Eight isolates of
serogroup O1, serotype Inaba, isolated from water in
Spain and from prawns in Ecuador were genetically
closely related (GT2). Three other isolates of Spanish ori-
gin were genetically related (GT3). Furthermore, three
pairs of closely related isolates were identified. Two pairs
were isolated from the Bug river in Poland (GT5, GT6),
while another pair was isolated in Norway from seawater
near Oslo (GT4). Six SLVs from Spain, Norway and
Poland were observed.
MALDI-TOF MS analysis
To obtain spectra of a wider m/z range than acquired
with HCCA as a matrix, whole cell extracts were ana-
lyzed with MALDI-TOF MS using FA+. Spectra wereinitially recorded in a mass-to-charge range of 4,000 to
80,000 (MZXML data available at http://www.learning-
machines.com/). As no significant peaks were visible
above an m/z value of 50,000, spectra were recorded up
to m/z = 50,000 in following experiments (Figure 2).
After the datasets were normalized, the baseline was
subtracted, and data were aligned and normalized, a heat
map was generated to visualize differences between the
MS spectra (Figure 3). A simple algorithmic peak search
procedure allowed us to identify a prevalent peak near
an m/z value of 35,000 that appeared to be discrimin-
atory among the different genotypes (Figure 3). In the
spectra of all epidemic isolates of serogroups O1 and
O139 (GT1), this peak corresponded to an average mass
of 34,750 Da with a standard deviation of 22 Da except
for the O1 serotype Hikojima strain (35,424 Da). In the
spectra of the other isolates, the corresponding peak dif-
fered at least 70 Da from that of GT1 (Figures 3 and 4).
The peaks that were closest to the peak mass of the
GT1 spectra were those measured in the spectra of GT2,
the non-epidemic V. cholerae O1 Inaba isolates related
to a Spanish outbreak, which were 34,670 +/− 20 Da.
To test the reproducibility of the observed differences
in the discriminatory peak masses, the experiment was
repeated in a different manner in which isolates were
randomly distributed into separate sets. The results for
GT1 and GT2 are summarized in Table 2. The mean
peak masses of the specific marker in the GT1 and GT2
isolates were 34,565 +/− 31 Da and 34,495 +/− 30 Da,
corresponding to mean mass shifts of −185 and −175 Da,
respectively, compared to the first experiment. This shows
Figure 2 MALDI-TOF MS analysis of whole cell lysates of V. cholerae isolates. A and B, examples of normalized MS spectra of a toxigenic
and epidemic serogroup O1 isolate (A) and a non-toxigenic isolate (B). C and D, close-ups of selected MS-peak of Figure A and B, respectively. a,
m/z = 34,750 Da, b m/z = 34,690 Da.
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masses can deviate between separate experiments but that
differences between different samples are relatively con-
stant. By including an internal control of known mass,
spectra can be calibrated. Reproducibility was further sup-
ported by the median of the GT1 and GT2 measurements,
which were maximally 5 Da different from the mean, indi-
cating a Gaussian distribution of the measurements.
Identification of discriminatory peak as OmpU
One peak in the MS spectra representing the most
abundant protein in a mass range of 30 to 40 kDa in
V. cholerae cells grown overnight on rich medium
agar plates was suggested to be a biomarker to differenti-
ate between various V. cholerae strains. To identify this
protein, whole cell lysates were analyzed by SDS-PAGE(Figure 5). Protein extracts from eight isolates of four dif-
ferent genotypes: GT1, 2, 6 and a SLV, were prepared
from the same colony material that was used for MS ana-
lysis. One prominent band in the mass range of 32 –
37 kDa was present in the extracts of each of the isolates
except for isolate FFIVC129, the ‘Hikojima strain’, which
had two equally strong bands differing approximately
2 kDa in apparent mass. Differences in apparent masses
in the SDS-PAGE analysis correlated with the differences
of the peak masses in the MS spectra. The protein bands
were excised, trypsin digested and analyzed by LC-MS/
MS for identification. Of each band, the vast majority of
peptides was identified as derived from OmpU homologs,
except for the upper band of the Hikojima strain,
which was identified as OmpT (Mascot 2.2.1 analysis).
To confirm the correlation of the mass differences of
Figure 3 Heat map analysis of MS spectra of 48 V. cholerae isolates and one V. mimicus strain. Each isolate is represented by four spectra
(horizontal lanes) obtained from four spots on the MALDI target. The color indicates the peak intensities according to the color scale (left bar).
The spectra were divided into spectrogram groups (separated by red horizontal lines): 1, V. cholerae serogroup O139 (GT1); 2, V. cholerae serogroup
O1 serotype Hikojima and Ogawa strains (GT1); 3, serogroup O1 serotype Inaba (GT2); 4, SLVs; 5, serogroup O1 serotype Ogawa (2x) and Inaba
(1x) (GT3); 6 and 7, two pairs isolated from the Bug river in Poland (GT 4, GT5); 8, pair isolated in Norway (GT6); 10, V. mimicus.
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the ompU genes of 16 isolates were amplified and
sequenced. (Accession numbers: KF434513 - KF434521
and KJ699296 - KJ699302). The theoretical masses of the
mature OmpU homologs with omission of the signal
peptide correlated with the observed peak masses of the
MS spectra (less than 0.41% difference, Table 3) but not
well enough to identify an epidemic isolate on basis of
the measured peak mass alone. However, the theoretical
mass differences between the isolates were consistent
with the differences in the MS spectra within one ex-
periment. The amino acid sequences of OmpU pro-
teins from the epidemic V. cholerae O1 Ogawa and
O139 isolates (080025/EZ and FFIVC130, respectively)
were identical to the sequence of the OmpU protein
from the epidemic type strain V. cholerae O1 El Tor Inaba
N16961 (ATCC 39315) (Additional file 1: Figure S1). The
OmpU protein from the V. cholerae O1 serotype Hikojima
(isolate FFIVC129) differed at three positions (E290K,
V324A, G325S) causing a mass difference of only one
Dalton (OmpU N16961; 34,656 and OmpU FFIVC120;
34,657 Da). The OmpU proteins from the other tested
strains deviated more from this sequence (Table 3). The
OmpU proteins that were closest in mass were from thenon-toxigenic outbreak isolates 080025/FE and 080025/FI
(GT2), which differed at 9 positions, resulting in a 72 Da
lower mass. The resolution of the MALDI-TOF MS spec-
tra was sufficient to make this distinction (Table 3).
OmpU is conserved among epidemic V. cholerae strains
Using BLASTp, the amino acid sequence of mature
OmpU protein of V. cholerae N16961, which was used
as a reference, was screened against the NCBI protein
database (Table 4). At the time of preparation of this art-
icle, 181V. cholerae OmpU homologs were present in
the NCBI database. Ninety-six OmpUs were identical to
the reference OmpU (from strain N16961) and these
were all present in isolates of serogroup O1 or O139
that contain ctxAB and tcpA. One exception to this was
a V. cholerae isolate of serotype O37 (strain V52), which
was isolated during an outbreak in Sudan in 1968
(Table 4). This strain was shown to form a highly uniform
clone together with V. cholerae O1 and O139 [24]. Two
strains differed at one position from the reference
OmpU. For one of these homologs, no strain information
was provided. The OmpU of this isolate was 34 Da lower
in mass compared to the reference OmpU. From the
other isolate, CP1038(11), a V. cholerae O1 containing
Figure 4 Distribution of the highest-peak positions in the 32 to 38 kDa range grouped per genotype (GT). Each isolate is represented by
four peak positions. GT1 (O1/O139 Tox+) comprises 96 peak positions of 24 isolates; GT1 (O1 Hikojima Tox+) comprises 4 peak positions of 1
isolate; GT2 (O1, Tox-) 32 peak positions of 8 isolates; GT3 (O1 Tox-) shows 12 peak positions of 3 isolates with the same genotype but different
serotypes. GT4, GT5 and GT6 each comprise 8 peak positions of 2 isolates; SLVs comprise 20 peak positions of 5 not related isolates; V. mimicus
comprises 4 peak positions of one V. mimicus strain; Outlier comprises 4 peak positions of one outlier, in the second experiment for this isolate
the maximal difference in peak positions was 52 Da.
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http://www.biomedcentral.com/1471-2180/14/158ctxAB and tcpA OmpU has a 58 Da higher mass than the
reference OmpU from N16961 (Table 4). The OmpU
proteins from two closely related V. cholerae strains of
serogroup O1, the “Classical” biotype, RC27 (presence of
ctxAB unknown, tcpA +) and O395 (ctxAB + and tcpA+),
were identical to that of the O1 Hikojima strain tested in
this study (FFIVC129), having three amino acid muta-
tions compared to N16961 OmpU, which results in a
mass difference of 1 Da (Table 3). All other OmpU ho-
mologs retrieved in the BLASTp search contained ten
or more mutations compared to the reference OmpU,
resulting in a 58 Da lower mass in one case (strain
BJG-01) or 70 Da or more difference in all other cases. TheTable 2 MALDI-TOF MS data of selected biomarker peak (Om
V. cholerae O1/O139; GT2, non-toxigenic O1) obtained from t
GT 1a
Exp1 Exp2 Δ Exp1,E
Mean 34750 34565 −185
Median 34745 34565 −180
Maximum Δ 25 30
Minimum Δ 35 50
aO1 Hikojima isolate not included.isolates harboring these OmpUs were all non-O1/O139
strains, with the exception of two O1 strains. However, no
ctxAB or tcpA genes were found in the genome sequences
of these strains, which strongly suggests that these are
non-epidemic strains.
In addition to the screening of OmpU homologs present
in the NCBI protein database, 149 ompU sequences identi-
fied in completed whole genome sequences or whole gen-
ome shotgun (WGS) data of V. cholerae isolates available
in the NCBI database were analyzed, and concomitantly,
screened for the presence of the toxigenicity genes ctxA
and tcpA. Based on sequence similarity with the O-antigen









Figure 5 SDS-PAGE analysis of whole cell fractions of eight V. cholerae isolates. Lane 1, FFIVC129 ‘Hikojima’ isolate; 2, FFIVC130; 3, 080025/EZ; 4,
080025/FC; 5, 080025/FE; 6, 080025/FI; 7, FFIVC137; 8, 17/110/2006. Bands indicated with an asterisk were excised from the gel, in-gel digested with
trypsin and analyzed by LC-MS/MS. All bands were identified as OmpU homologs except the upper band of strain FFIVC129 (V. cholerae O1 serotype
Hikojima Tox + GT1), which was identified as OmpT.
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The amino acid sequence variation in OmpU in the
102 strains that also contained ctxA and tcpA was lim-
ited. In nine strains (including CP1038(11)) there was
one amino acid difference compared to reference
OmpU, resulting in 58 and 48 Da higher mass for eight
strains and one strain, respectively. The variation in
OmpU from six serogroup O1 isolates not harboringTable 3 Theoretical and measured masses of OmpUs of 16 V.
Isolate GT Theoretical
massa Δb
080025/EZ 1 34656 0
FFIVC130 1 34656 0
FFIVC129 1 34657 + 1
FFIVC114 4 35595 + 939
080025/FE 2 34584 - 72
080025/FI 2 34584 - 72
080025/FL 3 35566 + 910
17/110/2006 6 33871 - 785
2/110/2006 5 34961 + 305
080025/FR singleton 34870 + 214
080025/GE 3 35566 + 910
FFIVC050 singleton 33840 - 816
FFIVC084 singleton 34811 + 155
FFIVC137 singleton 35709 + 1053
4/110/2006 singleton 34122 - 534
14/110/2006 singleton 34826 + 170
aTheoretical mass of mature OmpU in Da.
bDifference in mass with theoretical mass of OmpU of isolate 080025/EZ, in Da.
cMean of peak masses obtained from 4 different MALDI spots.
dThe average of OmpU peak masses of strain 080025/EZ and FFIVC130 was set as r
eN.D.: not determined, as OmpT instead of OmpU was assigned as the major peak i
fN.D.: not determined because of failed measurement.ctxA and tcpA differed 70 Da or more, similar to
what was found with the BLASTp search. From the
41 analyzed non-O1/O139 strains the OmpU mass
was in one case (strain BJG-01) 58 Da lower than that
of the reference OmpU (see also BLASTp search) and in
all other cases differed more than 70 Da.
It was shown that OmpU homologs differing 72 Da
in theoretical mass (GT1 and GT2) could be wellcholerae isolates
Measured
1st exp 2nd exp
massc Δ refd massc Δ refd
34755 + 6 34567 + 12
34742 - 6 34543 - 12
N.D.e N.D.e
35683 + 934 35506 - 951
34672 - 77 34482 - 73
34678 - 71 34508 - 47
35656 + 907 35469 + 914
33975 - 774 33733 - 822
35031 + 282 34875 + 320
34951 + 203 34784 + 229
35670 + 922 35501 + 946
33924 - 824 33748 - 807
34884 + 136 34683 + 128
35813 + 1065 N.D.f
34198 - 550 33977 - 578
N.D.f 34716 + 161
eference.
n the 30000 – 40000 m/z range.
Table 4 Results of BLASTp search using OmpU of Vibrio cholerae O1 El Tor N16961 (calculated molecular mass






Strain Serogroup Serotype Biotype Origin Year of
isolation
ctxABa tcpAa Epidemic (E) or
non-epidemic
strain (N)
1 34656 N16961 O1 Inaba El tor Bangladesh 1975 ctxAB+ tcpA+ E
1 34656 CP1032 (5) O1 Ogawa El tor Mexico 1991 ctxAB+ tcpA+ E
1 34656 CP1044 (17) O1c Peru 1991 ctxAB+ tcpA+ E
1 34656 4260B O139 Bangladesh 1993 ctxAB+ tcpA+ E
1 34656 CP1046 (19) O1c Peru 1995 ctxA+,
ctxBf
tcpA+ E
1 34656 CP1047 (20) O1c Peru 1995 ctxAB+ tcpA+ E
1 34656 CP1033 (6) O1c Mexico 2000 ctxAB+ tcpA+ E
1 34656 CIRS101 O1 Inaba El tor Bangladesh 2002 ctxAB+ tcpA+ E
1 34656 CP1037 (10) O1 Mexico 2003 ctxA+,
ctxB-f
truncated E
1 34656 CP1040 (13) O1c Zambia 2004 ctxAB+ tcpA+ E
1 34656 CP1041 (14) O1 Ogawa El tor Zambia 2004 ctxAB+ tcpA+ E
1 34656 CP1030 (3) O1c Mexico 2008 ctxAB+ tcpA+ E
1 34656 HC-06A1e O1 Ogawa El tor Haiti 2010 ctxAB+ tcpA+ E
1 34656 CP1042 (15) O1 Ogawa El tor Thailand 2010 ctxAB+ tcpA+ E
1 34656 CP1048 (21) O1 Ogawa El tor Bangladesh 2010 ctxAB+ tcpA+ E
1 34656 CP1050 (23) O1c Bangladesh 2010 ctxAB+ tcpA+ E
2b 34656 M66-2 O1 - - Indonesia 1937 ctxA+,
ctxB-f
tcpA+ E
2 34656 MAK 757 O1 Ogawa El Tor Indonesia 1937 ctxAB+ tcpA+ E
2 34656 V52 O37 Sudan 1968 ctxAB+ tcpA+ E
2 34656 RC9 O1 Ogawa El Tor Kenya 1985 ctxAB+ tcpA+ E
2 34656 BX 330286 O1 Inaba El Tor Australia 1986 ctxAB+ tcpA+ E
2 34656 MO10 O139 India 1992 ctxAB+ tcpA+ E
2 34656 MJ-1236 O1 Inaba El Tor Bangladesh 1994 ctxAB+ tcpA+ E
2 34656 B33 O1 Ogawa El Tor Mozambique 2004 ctxAB+ tcpA+ E
3 F287I 34622 unknown unknown El tor unknown unknown unknown
4 G325D 34714 CP1038 (11) O1 Ogawa El tor Zimbabwe 2003 ctxAB+ tcpA+ E
5 E290K, V324A,
325S
34657 RC27 O1 Classical Indonesia 1991 truncated truncated N
5 E290K, V324A,
325S
34657 O395 O1 Ogawa Classical India 1965 ctxAB+ truncated N
7 10 mut 34598 BJG-01 non-O1d ctxA+,
ctxB-f
unknown N
8 9 del , 13 mut 33840 HE-25 non-O1d Haiti 2010 ctxAB - tcpA - N
9 9 del, 13 mut 33840 AM-19226 O39 Bangladesh 2001 ctxAB - tcpA - N
10 7 del, 18 mut 33911 RC385 O135 USA 1998 ctxAB - tcpA - N
actxAB and tcpA genes were identified by blastx search of whole genome sequences using ctxAB and tcpA of strain N16961 as query sequences.
bHit nr. 2 represents OmpU identical to hit nr. 1 except for nine additional N-terminal residues resulting from a wrongly identified translation start.
cPresumed serotype O1 based on sequence similarity with O-antigen biosynthesis genes VC0241 to VC0244A from N16961.
dPresumed serotype non-O1/O139, based on lack of sequence similarity with O-antigen biosynthesis genes VC0241 to VC0244A from N16961 and O139. Accession:
AB012956 bp 22084–24660 wbfH/wbfI/wbfJ ).
eThis strain represents also 44 other Vibrio cholerae O1 El Tor Ogawa isolates from same outbreak with identical OmpU sequence and toxigenicity genes.
fNo ctxB similar to ctxB of N16961 (locus_tag;VC1456). Presence of another variant of ctxB cannot be excluded.
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080025/GE (GT3) and FFIVC114 (GT4), which differed
by only 29 Da in mass (GT3 (080025/FL, 080025/GE) and
GT4 (FFIVC114)). Therefore, it can be assumed that
OmpUs from epidemic strains (34,656 Da to 34,714 Da)
can be distinguished from non-epidemic V. cholerae strains
(less than 34,598 Da or more than 34,734 Da).
Discussion
In this study, we demonstrate that the outer membrane
protein OmpU from V. cholerae can be used as a bio-
marker of epidemic strains of V. cholerae in a new
adapted MALDI-TOF MS assay. The use of ferulic acid
as a matrix instead of α-cyano-4-hydroxycinnamic acid,
commonly used in standardized MALDI-TOF assays for
identification of bacteria, allowed for a larger measurable
mass range (4 – 80 kDa), thereby including larger
proteins such as OmpU (34 kDa) in the analysis. The
resolution of the spectra was sufficient to discriminate
between epidemic V. cholerae O1/O139 strains and
other less pathogenic strains on the basis of mass differ-
ences in OmpU. OmpU appeared to be the dominant
peak in an m/z range of 30,000 – 40,000 in the spectra
of all 48 tested strains except for the spectrum repre-
senting the V. cholerae O1 strain of serotype Hikojima,
where the most dominant peak was identified as OmpT.
OmpU and OmpT are major outer membrane proteins
of V. cholerae [25]. OmpU is expressed when cells are
colonizing a human host, while OmpT is repressed at
this time [26]. Reproducible differences between the
OmpU peak masses of different MLST genotypes ran-
ging from 32.4 to 35.7 kDa enabled discrimination of
epidemic isolates from less or non-pathogenic isolates.
Sequencing of the ompU genes in V. cholerae isolates
representing different genotypes and a database analysis
revealed that the amino acid sequence of OmpU from
the epidemic V. cholerae O1/O139 and O37 strains is
highly conserved, while OmpU homologs from other
V. cholerae isolates varied from this sequence. These dif-
ferences in amino acid sequence resulted in almost all
cases in mass differences of more than 70 Da, which was
sufficient to distinguish the “epidemic” OmpU proteins
from OmpU proteins of other strains with the resolution
of the method presented here. In general, differences in
OmpU peak masses between strains were well reprodu-
cible in multiple experiments. However, small variations
in the OmpU peak masses between separate experiments
were observed, indicating that the method requires in-
clusion of a standard sample for calibration containing a
characterized V. cholerae strain. Among the OmpU ho-
mologs of non-epidemic strains present in the NCBI
database, one had a theoretical mass of 58 Da less than
that of the “epidemic” OmpU protein, while in all other
non-epidemic V. cholerae isolates the mass differed morethan 70 Da. From the in silico analyzed 102 ‘epidemic’
isolates the theoretical mass of OmpU from eight, one
and two isolates differed 58, 48 and 1 Da, respectively.
Therefore, it can be assumed that epidemic strains
(34,656 Da to 34,714 Da) can be distinguished from
non-epidemic V. cholerae strains (less than 34,598 Da or
more than 34,734 Da) based on OmpU using the described
MALDI-TOF MS assay.
The V. cholerae strain of serotype Hikojima was shown
to produce both OmpU and OmpT (Figure 5). However,
in the obtained MS-spectra OmpU was not detected
well and therefore its peak mass was not determined.
More isolates of the Hikojima serotype, which is a rare
serotype, need to be tested to determine whether this re-
sult is strain or serotype specific [23]. The theoretical
mass of OmpU of the tested strain is only one Da less
than that of the N16961 OmpU.
It should be noted that not all strains of serogroup O1
are toxigenic. Some strains are not able to produce the
cholera toxin because these isolates lack the ctxAB and
tcpA genes necessary for full virulence of V. cholerae
[21,27]. Furthermore, the non-toxigenic O1 isolates in
this study were also genetically distinct from the epi-
demic V. cholerae O1/O139 cluster (GT1), indicating
that other unknown virulence factors could be present
in the epidemic V. cholerae O1/O139 cluster that are
absent in non-toxigenic V. cholerae O1 isolates. Pre-
vious studies have shown the presence of non-toxigenic
V. cholerae O1 strains in the environment and in humans
[6,18,21,27]. Serotyping is therefore not a reliable method
for the identification of toxigenic and epidemic V. cho-
lerae O1/O139 strains. Furthermore,V. cholerae non-O1/
O139 isolates have been described that are able to pro-
duce the cholera toxin but are not considered epidemic
because only strains of serogroup O1/O139 and O37 are
able to cause large outbreaks [6,21,27]. Thus, the pres-
ence of the ctxAB and tcpA genes is not the only pre-
requisite for epidemic potential.
We have found that OmpU from epidemic V. cholerae
has a unique and conserved amino acid sequence, which
not only can be used in the presented MALDI-TOF MS
assay, but also in a targeted PCR method. The difference
in OmpU sequences between epidemic and non-epidemic
isolates as well as the sequence variation among non-
epidemic strains raises the question of whether this
variation is due to genetic drift or specific adaptation to
different niches. From a DNA alignment of a 5,000 bp
region surrounding the ompU gene of seven epidemic
O1 and five non-toxigenic strains (Additional file 2:
Figure S2), it became clear that the ompU gene has
undergone a higher mutation rate compared to the sur-
rounding genes and intergenic regions. This suggests that
OmpU has been subject to selective pressure, possibly as
a result of adaptation to particular niches. A role for
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tially in enhancing attachment to epithelia in the gut
or conferring resistance to bile, ionic detergents and
organic acids [28-31]. Based on a three-dimensional
model of V. cholerae OmpU, most of the variable regions
are located in regions exposed to the outside of the cell
(not shown), which supports a host-dependent variation
hypothesis.Conclusions
Each year more than half a million people develop chol-
era. To reduce the burden of this devastating disease,
new strategies must be developed. By minimizing the
spread of the pathogen, the disease incidence can be
reduced. To control a cholera outbreak, quick identifi-
cation at the start of a potential outbreak and rapid dis-
crimination between epidemic V. cholerae and other
V. cholerae isolates could be helpful in introducing effective
hygienic measurements [32,33]. To this point, discrimin-
ation between the toxigenic and epidemic V. cholerae
strains and the non-pathogenic or less pathogenic strains
has required multiple tests. The deviation in amino acid
sequences of OmpU homologs of non-epidemic strains
from those of the OmpU protein of strain N16961,
which is conserved among almost all epidemic strains,
makes OmpU an important biomarker to discrimin-
ate between epidemic V. cholerae O1/O139 and other
V. cholerae isolates. The mass differences of OmpU pro-
teins resulting from this sequence variation together with
the high abundance of this protein in bacteria allows for
the use of MALDI-TOF MS analysis as a rapid and
discriminatory method for identifying epidemic strains
of V. cholerae. Based on the described classification
technique, one would maximally generate only one
false negative classification when all characterized and
sequenced V. cholerae isolates are screened with the
developed MALDI-TOF MS assay.Additional files
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